PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SGRY vs. HCA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SGRY and HCA is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

SGRY vs. HCA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Surgery Partners, Inc. (SGRY) and HCA Healthcare, Inc. (HCA). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-24.87%
-18.30%
SGRY
HCA

Key characteristics

Sharpe Ratio

SGRY:

-0.47

HCA:

0.13

Sortino Ratio

SGRY:

-0.44

HCA:

0.34

Omega Ratio

SGRY:

0.95

HCA:

1.05

Calmar Ratio

SGRY:

-0.35

HCA:

0.12

Martin Ratio

SGRY:

-1.12

HCA:

0.26

Ulcer Index

SGRY:

22.23%

HCA:

12.83%

Daily Std Dev

SGRY:

53.67%

HCA:

25.80%

Max Drawdown

SGRY:

-80.21%

HCA:

-54.74%

Current Drawdown

SGRY:

-62.25%

HCA:

-23.69%

Fundamentals

Market Cap

SGRY:

$3.22B

HCA:

$78.58B

EPS

SGRY:

-$0.47

HCA:

$21.99

PEG Ratio

SGRY:

1.66

HCA:

1.01

Total Revenue (TTM)

SGRY:

$2.25B

HCA:

$70.60B

Gross Profit (TTM)

SGRY:

$478.30M

HCA:

$35.61B

EBITDA (TTM)

SGRY:

$340.40M

HCA:

$13.88B

Returns By Period

In the year-to-date period, SGRY achieves a 19.56% return, which is significantly higher than HCA's 5.42% return.


SGRY

YTD

19.56%

1M

24.37%

6M

-24.87%

1Y

-22.98%

5Y*

6.42%

10Y*

N/A

HCA

YTD

5.42%

1M

-0.97%

6M

-18.30%

1Y

1.93%

5Y*

17.42%

10Y*

17.02%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SGRY vs. HCA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SGRY
The Risk-Adjusted Performance Rank of SGRY is 2222
Overall Rank
The Sharpe Ratio Rank of SGRY is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of SGRY is 2222
Sortino Ratio Rank
The Omega Ratio Rank of SGRY is 2323
Omega Ratio Rank
The Calmar Ratio Rank of SGRY is 2626
Calmar Ratio Rank
The Martin Ratio Rank of SGRY is 1818
Martin Ratio Rank

HCA
The Risk-Adjusted Performance Rank of HCA is 4747
Overall Rank
The Sharpe Ratio Rank of HCA is 5151
Sharpe Ratio Rank
The Sortino Ratio Rank of HCA is 4242
Sortino Ratio Rank
The Omega Ratio Rank of HCA is 4242
Omega Ratio Rank
The Calmar Ratio Rank of HCA is 5252
Calmar Ratio Rank
The Martin Ratio Rank of HCA is 5050
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SGRY vs. HCA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Surgery Partners, Inc. (SGRY) and HCA Healthcare, Inc. (HCA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SGRY, currently valued at -0.47, compared to the broader market-2.000.002.00-0.470.13
The chart of Sortino ratio for SGRY, currently valued at -0.44, compared to the broader market-4.00-2.000.002.004.006.00-0.440.34
The chart of Omega ratio for SGRY, currently valued at 0.95, compared to the broader market0.501.001.502.000.951.05
The chart of Calmar ratio for SGRY, currently valued at -0.35, compared to the broader market0.002.004.006.00-0.350.12
The chart of Martin ratio for SGRY, currently valued at -1.12, compared to the broader market-10.000.0010.0020.0030.00-1.120.26
SGRY
HCA

The current SGRY Sharpe Ratio is -0.47, which is lower than the HCA Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of SGRY and HCA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.47
0.13
SGRY
HCA

Dividends

SGRY vs. HCA - Dividend Comparison

SGRY has not paid dividends to shareholders, while HCA's dividend yield for the trailing twelve months is around 0.83%.


TTM2024202320222021202020192018
SGRY
Surgery Partners, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
HCA
HCA Healthcare, Inc.
0.83%0.88%0.89%0.93%0.75%0.47%1.08%1.12%

Drawdowns

SGRY vs. HCA - Drawdown Comparison

The maximum SGRY drawdown since its inception was -80.21%, which is greater than HCA's maximum drawdown of -54.74%. Use the drawdown chart below to compare losses from any high point for SGRY and HCA. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-62.25%
-23.69%
SGRY
HCA

Volatility

SGRY vs. HCA - Volatility Comparison

Surgery Partners, Inc. (SGRY) has a higher volatility of 20.07% compared to HCA Healthcare, Inc. (HCA) at 10.75%. This indicates that SGRY's price experiences larger fluctuations and is considered to be riskier than HCA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
20.07%
10.75%
SGRY
HCA

Financials

SGRY vs. HCA - Financials Comparison

This section allows you to compare key financial metrics between Surgery Partners, Inc. and HCA Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab